Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events


University of Illinois at Chicago, PhD 1990
University of Illinois at Urbana-Champaign, BS 1984

Current Companies

Chairman, Board of Directors

Former Companies

Director and CEO
CEO & Board of Directors
Show All Former Companies

Current Financial Organizations

Managing Member

Former Financial Organizations

Managing Director

Web Presences


Photo Credit

Jay Lichter

Jay Lichter, PhD is an experienced biotechnology and pharmaceutical business executive with 25 years of experience in management, scientific research, and business development.

He led Avalon VIII’s investments in and served as Director and CEO for Afraxis, Carolus, Otonomy, ReVision Therapeutics and Zacharon.

He also led the first life science investment for Avalon IX, Sova Pharmaceuticals and serves as the CEO and on the Board of Directors.

Throughout his career, Dr. Lichter has applied his exceptional combination of business acumen and deep technical knowledge to creating commercially successful biotech collaborations and identifying the commercial potential of scientific discoveries at their earliest stages.

Dr. Lichter is the inventor on 260 patent and patent applications for six Avalon portfolio companies, including 55 issued patents.

Dr. Lichter has been either directly responsible for or participated in licensing or merger and acquisition deals valued in excess of $1 billion.

Recent Milestones



Edit This Page
Last Edited 12/19/13

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy